A CRISPR/Cas9 TMEM165 knockout (KO) was generated using the Claudin-low human breast cancer cell line MDAMB231 with guide RNAs (gsRNA) to TMEM165 previously described [29]. The gene discussed is TMEM165; the disease is breast carcinoma.